Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Chromosome 22 open reading frame 42 pseudogene (C22orf42 pseudogene)** is a non-functional genomic sequence located on human chromosome 22 (annotated by Ensembl as ENSG00000285697)[1]. Pseudogenes are DNA segments that bear high similarity to protein-coding genes but lack the ability to produce a functional protein product due to sequence disruptions, absence of promoters, or other critical features[2]. Although historically regarded as “junk DNA,” recent research reveals that some pseudogenes are transcribed into noncoding RNAs that may impact gene regulation in various cellular contexts[4][6]. For the C22orf42 pseudogene, there is no evidence of protein product, direct biological function, or therapeutic relevance; it is classified by genomic databases as a processed pseudogene[1]. It is not recognized as a receptor, enzyme, transporter, or therapeutic target[1][2][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 22 open reading frame 42 pseudogene (C22orf42 pseudogene).